78,957 Shares in Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) Acquired by Strategic Financial Concepts LLC

Strategic Financial Concepts LLC bought a new position in shares of Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQFree Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 78,957 shares of the company’s stock, valued at approximately $1,699,000.

Separately, ORG Partners LLC bought a new position in Invesco Nasdaq Biotechnology ETF in the 3rd quarter valued at $25,000.

Invesco Nasdaq Biotechnology ETF Stock Performance

Shares of IBBQ opened at $22.26 on Tuesday. The stock has a fifty day moving average price of $22.16 and a two-hundred day moving average price of $23.18. Invesco Nasdaq Biotechnology ETF has a 52-week low of $20.14 and a 52-week high of $24.84. The company has a market cap of $39.40 million, a price-to-earnings ratio of 17.39 and a beta of 0.61.

Invesco Nasdaq Biotechnology ETF Announces Dividend

The company also recently announced a dividend, which was paid on Friday, December 27th. Stockholders of record on Monday, December 23rd were paid a $0.0619 dividend. The ex-dividend date of this dividend was Monday, December 23rd.

Invesco Nasdaq Biotechnology ETF Profile

(Free Report)

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.

Featured Articles

Want to see what other hedge funds are holding IBBQ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQFree Report).

Institutional Ownership by Quarter for Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ)

Receive News & Ratings for Invesco Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.